
|Videos|November 26, 2018
Recurrent HR+ Breast Cancer
Recurrent HR+ Breast Cancer
Advertisement
A 58-Year-Old Woman With Recurrent HR+ Breast Cancer
December 2013
- A 58-year-old postmenopausal woman was referred for further evaluation of a suspicious left-sided lesion found incidentally on routine mammogram
- MRI revealed a 4.3-cm lesion in her left breast
- PMH unremarkable
- She underwent lumpectomy with axillary staging
- Biopsy findings:
- Histology: lobular carcinoma, grade 2
- Hormone receptor status: ER+/ PR (-)
- HER2,IHC 1+
- OncotypeDx RS, 19
- Staging, T2N0M0
- ECOG 0
- She was started on adjuvant anastrozole
September 2018
- On routine follow-up, the patient reports increasing fatigue and intermittent bouts of abdominal pain with nausea
- CT with contrast showed several small lesions in the liver; biopsy confirmed metastatic disease.
- The patient was started on ribociclib; anastrozole was changed to fulvestrant
- Imaging at 3 and 6 months showed a partial response
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5







































